Skip to main content
. Author manuscript; available in PMC: 2024 Dec 1.
Published in final edited form as: Contemp Clin Trials. 2024 Mar 26;141:107516. doi: 10.1016/j.cct.2024.107516

Table 3.

Demographics and baseline characteristics.

Parameter Total
(N=459)
Age, years 49.7 (11.4)
  <50 221 (48.1%)
  ≥50 238 (51.9%)
Female 139 (30.3%)
Race
  American Indian or Alaska native 37 (8.1%)
  Asian 80 (17.5%)
  Black or African American 24 (5.2%)
  White 316 (69.0%)
  Multiple 1 (0.2%)
  Missing 1 (0.2%)
Ethnicity
  Hispanic or Latino 166 (36.2%)
  Not Hispanic or Latino 288 (62.7%)
  Not reported 5 (1.1%)
Region
  North America 32.0%
  South America 31.8%
  Europe 14.8%
  Asia-Pacific 21.4%
Weight, kg 115.0 (22.8)
BMI, kg/m2 38.8 (6.4)
  <35 140 (30.5%)
  ≥35 to <40 160 (34.9%)
  ≥40 159 (34.6%)
HbA1c, % 5.65 (0.4)
AHI, events/hour 50.1 (28.6)
OSA severity
  Moderate 152 (33.2%)
  Severe 299 (65.3%)
Waist circumference, cm 121.0 (14.6)
Neck circumference, cm 44.3 (4.7)
Prediabetes 283 (61.7%)
Dyslipidemia 383 (83.4%)
Hypertension 350 (76.3%)
ESS score 10.3
Sleep efficiency 75.8 (14.0)
Sleep onset 15.9 (20.8)
WASO, min 97.4 (59.8)
REM sleep, % 13.1 (7.1)

Note: Data are presented as mean (standard deviation) or n (%) unless otherwise noted.

Abbreviations: AHI, apnea-hypopnea index; BMI, body mass index; ESS, Epworth Sleepiness Scale; HbA1c, glycated hemoglobin; OSA, obstructive sleep apnea; REM, rapid eye movement; WASO, wakefulness after sleep onset.

HHS Vulnerability Disclosure